These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8255435)

  • 21. [Generic drugs in the treatment of epilepsy].
    González de Dios J; Ochoa-Sangrador C; Sempere AP
    Rev Neurol; 2005 Dec 1-15; 41(11):676-83. PubMed ID: 16317637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generic antiepileptic drugs-Safe or harmful in patients with epilepsy?
    Holtkamp M; Theodore WH
    Epilepsia; 2018 Jul; 59(7):1273-1281. PubMed ID: 29894004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is bioavailability altered in generic versus brand anticonvulsants?
    Jankovic SM; Ignjatovic Ristic D
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):329-32. PubMed ID: 25440299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Approvable generic carbamazepine formulations may not be bioequivalent in target patient populations.
    Tothfalusi L; Endrenyi L
    Int J Clin Pharmacol Ther; 2013 Jun; 51(6):525-8. PubMed ID: 23611573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation of the biological availability of 2 carbamazepine preparations].
    Niedzielska K; Rosnowska M; Kuran W
    Neurol Neurochir Pol; 1986; 20(5):415-20. PubMed ID: 3295573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generic substitution of antiepileptic drugs: a systematic review of prospective and retrospective studies.
    Yamada M; Welty TE
    Ann Pharmacother; 2011 Nov; 45(11):1406-15. PubMed ID: 22028417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generic anticonvulsant use in children: do we have evidence to recommend brand formulations?
    Hamiwka LD
    Arch Neurol; 2009 Nov; 66(11):1417-8. PubMed ID: 19901177
    [No Abstract]   [Full Text] [Related]  

  • 28. Are there potential problems with generic substitution of antiepileptic drugs? A review of issues.
    Crawford P; Feely M; Guberman A; Kramer G
    Seizure; 2006 Apr; 15(3):165-76. PubMed ID: 16504545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of carbamazepine. Part I: A new bioequivalency parameter based on a relative bioavailability trial.
    Kayali A; Tuğlular I; Ertaş M
    Eur J Drug Metab Pharmacokinet; 1994; 19(4):319-25. PubMed ID: 7737233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generic vs. branded carbamazepine.
    Aita JF
    Nebr Med J; 1988 Nov; 73(11):322-3. PubMed ID: 3200346
    [No Abstract]   [Full Text] [Related]  

  • 31. Wellbutrin versus generic bupropion.
    Med Lett Drugs Ther; 2008 Jul; 50(1290):54-5. PubMed ID: 18617874
    [No Abstract]   [Full Text] [Related]  

  • 32. [Bio-equivalence and generic drugs. Studies of bio-equivalence. II. Special situations. Reflections on problems which may arise with drugs habitually used in neurology].
    Zapater P; Horga JF
    Rev Neurol; 2000 Jan 16-31; 30(2):146-54. PubMed ID: 10730322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Debate: Substitution of generic drugs in epilepsy: is there cause for concern?
    Gidal BE; Tomson T
    Epilepsia; 2008 Dec; 49 Suppl 9():56-62. PubMed ID: 19087118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analogs of generic preparations for the treatment of epilepsy: is their use safe?].
    Crawford P; Hall W; Chappell V; Collings J; Stewart A
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(10):29-31. PubMed ID: 11712265
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of brand versus generic antiepileptic drug adverse event reporting rates in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS).
    Rahman MM; Alatawi Y; Cheng N; Qian J; Plotkina AV; Peissig PL; Berg RL; Page D; Hansen RA
    Epilepsy Res; 2017 Sep; 135():71-78. PubMed ID: 28641219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generic products of antiepileptic drugs: a perspective on bioequivalence and interchangeability.
    Bialer M; Midha KK
    Epilepsia; 2010 Jun; 51(6):941-50. PubMed ID: 20384761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioequivalence and narrow therapeutic index drugs.
    Benet LZ; Goyan JE
    Pharmacotherapy; 1995; 15(4):433-40. PubMed ID: 7479195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prescription of generic drugs].
    Cadórniga Carro R
    An R Acad Nac Med (Madr); 1997; 114(3):495-509. PubMed ID: 9549137
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of absorption rate and bioavailability of two brands of carbamazepine.
    Revankar SN; Desai ND; Bhatt AD; Bolar HV; Sane SP; Gupta C; Kamat DV
    J Assoc Physicians India; 1999 Jul; 47(7):699-702. PubMed ID: 10778590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Generics of antiepileptic drugs].
    Maeder-Ingvar M; Foletti GB
    Rev Med Suisse; 2010 May; 6(247):907-9. PubMed ID: 20499577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.